Paper37218433
Effect of Vitamin D Supplementation on Graves' Disease: The DAGMAR Trial.
Grove-Laugesen D and 8 others. Thyroid, 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Effect of Vitamin D Supplementation on Graves' Disease: The DAGMAR Trial. Papers, record 37218433. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37218433
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Iodine Radioisotopes | Major topic |
| Graves Disease | Major topic |
| Adult | |
| Pregnancy | |
| Humans | |
| Female | |
| Male | |
| Treatment Outcome | |
| Antithyroid Agents | |
| Vitamins | |
| Dietary Supplements | |
| Vitamin D | |
| Recurrence |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02384668 | D-vitamin And Graves' Disease; Morbidity And Relapse Reduction | Derived from the trial | Yes |
Source ClinicalTrials.gov
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939785 | Vitamin D-VDR Signaling Across Thyroid Disorders: A Systematic Review of Molecular Mechanisms, Autoimmunity, Genetic Susceptibility, Experimental Evidence and Therapeutic Translation. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939785 | PubMed |
| 42093983 | Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42093983 | PubMed |
| 41599829 | The Role of Vitamin D in Autoimmune Thyroid Diseases: From Immunomodulation to Clinical Implications. | Nutrients | 2026 | https://conductscience.org/library/papers/41599829 | PubMed |
| 41599655 | Vitamin D in Endocrine Disorders: A Broad Overview of Evidence in Musculoskeletal, Thyroid, Parathyroid, and Reproductive Disorders. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41599655 | PubMed |
| 41585809 | Case Report: Resolution of complete heart block following vitamin D supplementation in a child with Graves disease. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41585809 | PubMed |
| 41395273 | Type 1 Diabetes Autoimmunity: To What Extent Vitamin D is Beneficial. | Biochem Res Int | 2025 | https://conductscience.org/library/papers/41395273 | PubMed |
| 41141249 | Vitamin D deficiency as a potential risk factor for thyroid cancer: a clinical perspective. | Front Nutr | 2025 | https://conductscience.org/library/papers/41141249 | PubMed |
| 40873557 | High-dose Vitamin D supplementation for immune recalibration in autoimmune diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/40873557 | PubMed |
| 40104316 | Effects of vitamin D replacement combined with Graves' disease therapy: a retrospective cohort study. | Turk J Med Sci | 2025 | https://conductscience.org/library/papers/40104316 | PubMed |
| 39264438 | Changes in bone density and microarchitecture following treatment of Graves' disease and the effects of vitamin D supplementation. A randomized clinical trial. | Osteoporos Int | 2024 | https://conductscience.org/library/papers/39264438 | PubMed |
| 38919472 | Association of circulating vitamin levels with thyroid diseases: a Mendelian randomization study. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38919472 | PubMed |
| 38553734 | Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study. | J Transl Med | 2024 | https://conductscience.org/library/papers/38553734 | PubMed |
| 38259461 | A Mendelian randomization study of the effect of serum 25-hydroxyvitamin D levels on autoimmune thyroid disease. | Front Immunol | 2023 | https://conductscience.org/library/papers/38259461 | PubMed |
| 38004154 | The 2023's Growing Evidence Confirming the Relationship between Vitamin D and Autoimmune Diseases. | Nutrients | 2023 | https://conductscience.org/library/papers/38004154 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37218433
GET https://conductscience.org/api/papers/v1/37218433/authors